U.S. markets close in 1 hour 50 minutes
  • S&P 500

    4,120.43
    +64.44 (+1.59%)
     
  • Dow 30

    33,721.70
    +419.83 (+1.26%)
     
  • Nasdaq

    12,114.80
    +260.45 (+2.20%)
     
  • Russell 2000

    1,748.05
    +17.64 (+1.02%)
     
  • Crude Oil

    74.72
    +0.42 (+0.57%)
     
  • Gold

    1,998.30
    +2.30 (+0.12%)
     
  • Silver

    25.19
    +0.12 (+0.49%)
     
  • EUR/USD

    1.1024
    -0.0026 (-0.23%)
     
  • 10-Yr Bond

    3.5220
    +0.0900 (+2.62%)
     
  • GBP/USD

    1.2482
    +0.0017 (+0.14%)
     
  • USD/JPY

    133.9980
    +0.3810 (+0.29%)
     
  • Bitcoin USD

    29,276.68
    -459.68 (-1.55%)
     
  • CMC Crypto 200

    640.12
    +4.80 (+0.76%)
     
  • FTSE 100

    7,831.58
    -21.06 (-0.27%)
     
  • Nikkei 225

    28,457.68
    +41.21 (+0.15%)
     

Bristol Myers Squibb Posts Lower Q1 Sales As Revlimid Generic Erosion Bites, Chairman & CEO Giovanni Caforio To Step Down

  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

View more earnings on BMY

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

This article Bristol Myers Squibb Posts Lower Q1 Sales As Revlimid Generic Erosion Bites, Chairman & CEO Giovanni Caforio To Step Down originally appeared on Benzinga.com

.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.